Skip to main content

Mood Guide

Find clear information about services, treatments, research, and practical next steps.

Mood Guide provides general information from this website. It is not medical advice. Do not enter personal health information.
Safety Ask Results

No personal health details.

Resources

Patients & Families

SPRAVATO® and IV ketamine visit expectations

Understand monitored SPRAVATO® and IV ketamine visits, possible treatment-related reactions, and how the care team provides support.

Content

Lisa Harding MD discusses advanced depression treatment options

Knowing what a monitored treatment visit may feel like can make it easier to ask for support. SPRAVATO® and IV ketamine differ in administration, visit timing, and clinical requirements. Your team will explain the plan for your treatment. Sensations also vary between people and between visits, so another patient's account should not become a checklist of what you expect to experience.

The SPRAVATO Medication Guide describes possible effects including sleepiness, dizziness, nausea, and dissociation, which can involve feeling disconnected from yourself or your surroundings. Blood pressure can also rise, and monitoring includes attention to breathing. IV ketamine has a separate clinical plan, including discussion of possible effects and observation. Ask the treating clinician which effects are relevant to your treatment and what the team will be watching for.

I provide calm support when a patient feels nauseated, dizzy, anxious, unusually warm, or distressed by an unfamiliar sensation. Tell the team promptly about discomfort, vomiting or dry heaving, or anything that feels different. We communicate concerns to the clinician rather than expecting patients to decide whether a symptom is routine. Trouble breathing, chest pain, or a severe or rapidly worsening symptom needs immediate staff attention.

For anxiety or distressing dissociation, reassurance, grounding, and gentle breathing may help a patient feel more settled while the team continues appropriate observation. You can ask someone to explain what is happening or help you focus on the room around you. These measures accompany clinical monitoring; they do not replace assessment of a possible medical problem or mean that physical symptoms are assumed to be anxiety.

Questions about nausea prevention or medication for symptoms belong with the treating clinician. The plan may differ according to your history and how you have tolerated prior visits. There is no universal premedication routine to start on your own. Tell the team what happened after previous treatments, including delayed symptoms, so the clinician can consider that information before the next visit.

For SPRAVATO, monitoring continues for at least two hours and until the clinician determines you are ready to leave. Plan your transportation and follow the discharge instructions; do not drive until the next day after a restful sleep. Before leaving, ask what to watch for at home and how to contact the team. Sharing what you experience helps the team provide attentive support throughout the course of care.

Sources: SPRAVATO — prescribing information and Medication Guide

Contact Mood Institute

Ready to continue the conversation?